Loss of tumor STK11/LKB1 function not only decreased the phosphorylation/activation of its downstream target AMPK but also was associated with a change in tumor immune composition characterized by decreased monocytes, macrophages, and dendritic cells within the tumor microenvironment as also observed by others (11). This evidence concerns the gene STK11 and neoplasm.